Abdominal Pain (Pain, Abdominal)

10/01/2018 - "Anaemia (OR 6.9; p = 0.02) and surgery (OR 10.5; p < 0.01) were the only independent factors for unfavorable outcome (death), while abdominal pain (OR 0.1; p = 0.03) and antibiotics administration (OR 0.06; p < 0.001) were associated with better outcome. "
01/01/2020 - "The evidence showed that FKQJ combined with antibiotics improved the markedly effective rate compared to antibiotics alone group (RR = 1.38, 95% CI 1.27 to 1.49, I 2 = 42%), shortened the improvement time of low abdominal pain (MD = -1.11, 95% CI -1.39 to -0.84, I 2 = 38%), and increased the rate of lower abdominal pain improvement (RR = 1.35, 95% CI 1.19 to 1.55, I 2 = 0). "
07/01/2014 - "After 2 years of follow-up, recurrences of nonoperatively treated right lower quadrant abdominal pain are less than 14% and may be safely and effectively treated with further antibiotics."
11/01/2022 - "His abdominal pain improved with fasting and intravenous antibiotics. "
01/01/2012 - "Treatment with an antibiotic improved the inflammatory signs; however, on the 11th hospital day, the patient complained of sudden severe abdominal pain. "

01/01/2023 - "Research suggests that opioid treatment for abdominal pain, which comprises a large proportion of patients presenting to the emergency department (ED), may contribute to long-term opioid use without significant benefits with regard to symptom management. "
01/01/2022 - "While effective in treating abdominal pain, opioids have significant side effects. "
08/08/2017 - "Furthermore, well-designed clinical trials are needed to evaluate the effectiveness of long-term use of opioid medications, and more clinical research on which opioid medication is more effective for chronic abdominal pain."
01/01/2007 - "We hold that current evidence supports the administration of opioids to children with acute abdominal pain, and future trials will help determine safe and effective timing and dosing related to opioid administration."
08/08/2017 - "All studies were considered eligible for inclusion if they were clinical studies evaluating the efficacy of opioid medications for chronic abdominal pain. "

05/01/2017 - "The overall information tends to support the efficacy of Dysphania graveolens as an analgesic and its cultural use in abdominal pain."
12/01/2020 - "Regarding safety, only two cases of mild abdominal pain were recorded in two subjects with pancreatic head lesion, which were effectively treated with analgesics. "
09/01/2021 - "We present a case of 36-year-old pregnant woman gravida 10 para 7 abortus 2 at 36 + 5 weeks of gestation presenting twice for an increasing left abdominal pain, not relieved despite analgesics. "
01/01/2020 - "The use of Saccharomyces cerevisiae CNCM I-3856 in IBS at a dose of 2 billion CFU twice daily for 8 weeks has shown to have an improvement in abdominal pain and stool consistency due to its analgesic and anti-inflammatory activity in subjects with IBS."
03/01/2016 - "The purpose of this study was to determine attitudes anddaily practices of emergency medicine (EM) specialists, residents and faculty members in Turkey on the use of analgesics in patients with acute abdominal pain and factors affecting their decisions on the use of analgesics. "

03/01/2014 - "Most linaclotide-treated IBS-C patients who were FDA non-responders reported some improvement in abdominal pain and stool frequency, and global relief/satisfaction. "
05/01/2018 - "Secondary 12-week change-from-baseline endpoints (spontaneous bowel movement/complete spontaneous bowel movement frequency, stool consistency, straining, abdominal pain, abdominal discomfort, and abdominal bloating) were significantly improved with linaclotide versus placebo (all P < 0.0001). "
10/01/2013 - "Data from Phase II and III clinical trials demonstrated that linaclotide seems to produce a statistically significant increase in stool frequency, improved straining, decreased abdominal pain and discomfort."
01/01/2013 - "A significantly greater proportion of linaclotide-treated vs. placebo-treated patients were 12-week abdominal pain/discomfort responders (Trial 31: 54.8% vs. 41.8%; Trial 302: 54.1% vs. 38.5%; P < 0.001) and IBS degree-of-relief responders (Trial 31: 37.0% vs. 18.5%; Trial 302: 39.4% vs. 16.6%; P < 0.0001). "
12/01/2018 - "Secondary endpoints including responder rates for SBM and abdominal pain/discomfort relief in the linaclotide group were also significantly greater than those in the placebo group. "

04/15/2022 - "Regarding gastrointestinal manifestations, steroids are effective in reducing abdominal pain. "
01/01/2018 - "Transversus abdominis plane steroid injection can be a helpful in treating somatosensory chronic abdominal pain resistant to other therapeutic modalities."
01/01/2018 - "Efficacy of Transversus Abdominis Plane Steroid Injection for Treating Chronic Abdominal Pain."
06/01/2011 - "Steroid usage was associated with higher incidence of abdominal pain (87.5%) at the time of the study as compared to no steroid usage (40.9%), p = 0.0065. "
01/01/1990 - "We emphasize the clinical manifestations, which were masked by the antiinflammatory properties of the steroids; for this reason, careful and repeated physical exams should be made out in the case of any episode of abdominal pain in these patients, as well as ancillary studies for early diagnosis. "

03/01/2023 - "There were no significant differences between the 2 groups regarding white blood cell count, C-reactive protein, maximum body temperature, or scores on a verbal rating scale that assesses the degree of abdominal pain. "
10/01/2022 - "Moreover, both the duration of pre-operative abdominal pain and pre-operative C-reactive protein levels was found to significantly correlate with the duration of hospitalization (p<0.001 and p<0.001, respectively). "
01/01/2022 - "Children with abdominal pain were more likely to have elevated C-Reactive Protein (P = 0.037). "
11/16/2021 - "Elevated C-reactive protein (CRP) (OR, 14.09; 95% CI, 2.81-70.60; p = 0.001) and erythrocyte sedimentation rate (ESR) (OR, 14.45; 95% CI, 0.92-227.33; p = 0.06) indicated VCE-positive findings in patients with unexplained abdominal pain. "
11/01/2021 - "A 68-year-old woman with abdominal pain and a raised C-reactive protein was investigated with a CT of the abdomen. "

07/01/2003 - "Although lamina propria T-lymphocyte counts decreased significantly after prednisolone (22.0% +/- 5.6%, P = 0.003), but not after placebo (11.5% +/- 8.6%, P = 0.1), this was not associated with any significant treatment-related improvement in abdominal pain, diarrhoea, frequency or urgency. "
03/01/2012 - "After the administration of oral prednisolone 40 mg daily for therapeutic trial, abdominal pain and endoscopic lesions were improved. "
06/01/2008 - "The patient was referred to our hospital because of severe abdominal pain that was unresponsive to prednisolone. "
03/01/2005 - "Seventeen days after operation, intermittent abdominal pain occurred again, and subsided upon 30 mg per day treatment with prednisolone. "
01/01/2002 - "The abdominal pain became exacerbated after the administration of oral prednisolone. "

08/01/1991 - "The study population included 133 consecutive patients with a chief complaint of abdominal pain who had amylase drawn over a 2-week period at a university hospital ED. "
08/11/2023 - "Amylase use in abdominal pain evaluation showed sensitivity of 30%, specificity of 92%, PPV of 26%, NPV of 93%, and LR of 7.1 (P = 0.008). "
08/11/2023 - "Utility of Serum Amylase in Children With Abdominal Pain in the Pediatric Emergency Department."
12/01/2022 - "Collectively, ERCP in the treatment of ABP was associated with relief of abdominal pain, accelerated intestinal exhaust and serum amylase recovery, and effective improvements in serum biochemical parameters and inflammatory factor levels."
01/01/2022 - "Stata15.1 was used for quantitative analysis of total effectiveness rate, time until relief of abdominal pain, time until relief of abdominal distension, and serum amylase level. "

06/01/1997 - "Differential therapeutic strategies, including corticosteroid, had improved the symptoms which were dominated by abdominal pain. "
04/01/2022 - "A 71-year-old woman with GCA on corticosteroids presented with vague abdominal pain at a routine follow-up appointment. "
01/01/2020 - "Corticosteroids have been shown to reduce and/or ameliorate the occurrence of abdominal pain which may be severe. "
12/01/2012 - "A 57 year-old man with a history of corticosteroid use presented with abdominal pain and diarrhoea. "
08/01/2011 - "Early systemic corticosteroid administration due to severe abdominal pain did not prevent severe renal involvement."

01/01/2019 - "Rifaximin was not associated with significant improvement in global symptoms, abdominal pain, bloating, stool urgency, frequency, or consistency (all P ≥ 0.25) or QOL (all P ≥ 0.26). "
12/01/2016 - "The percentage of responders for abdominal pain (50.6% vs 42.2%; P = .018) was significantly greater with rifaximin than placebo, but not stool consistency (51.8% vs 50.0%; P = .42). "
08/01/2011 - "In addition, more patients in the rifaximin group than in the placebo group (p < 0.001) reported an adequate relief of bloating, and an improvement in abdominal pain and stool consistency - secondary outcome measures. "
03/23/2023 - "This study investigated changes in the fecal microbiome of patients with SUDD after repeated monthly treatment with rifaximin and the association of these changes with the severity of abdominal pain. "
11/01/2013 - "We recorded one serious adverse event in a participant in the rifaximin group who had grade 3 right lower quadrant abdominal pain 72 h after the last intake of study drug. "

04/12/2011 - "This combination therapy was partially successful, resulting in almost complete disappearance of abdominal pain and a marked decrease in stool frequency. "
12/01/2022 - "After PERT therapy, patients had significantly improved stool frequency, stool consistency, abdominal pain, distension and IBS severity score."
01/01/2021 - "CAM therapies such as herbal or dietary supplements and mind-body based approaches may be beneficial for abdominal pain and overall response in IBS. "
01/01/2017 - "After just one cycle of therapy a significant reduction in disease symptoms was observed (abdominal pain, abdominal tenderness, bloating, disturbances in bowel habit), defined over a scale of 0-3 points. "
02/01/2007 - "The hypereosinophilic condition improved rapidly and dialysis therapy was restarted successfully without causing abdominal pain. "

06/15/2022 - "A statistically significant improvement of symptoms (i.e., bloating, and abdominal pain) was reported in FI patient after treatment. "
07/01/2008 - "The symptoms of hemafecia and abdominal pain were improved, the disease active index (DAI) was lowered after treatment in both groups (P <0.01), but the improvement of hemafecia, time of disappearance of mucous bloody stool and decrease of DAI in the treatment group were superior to those in the control group (P <0.05 or P <0.01). "
01/05/2021 - "After treatment, half of the IBS-patients were relieved of bloating, while the majority no longer experienced abdominal pain and achieved a daily consistent stool. "
05/01/2020 - "The abdominal pain was not relieved after treatment. "
09/01/2014 - "The patient's chief complaints of right upper abdominal pain and abdominal fullness remarkably improved after treatment initiation. "

04/01/2023 - "Although the patient initially had right-sided abdominal pain, it gradually improved with conservative treatment. "
04/01/2020 - "In group A, 6 patients had recurrent abdominal pain, three of whom underwent invasive intervention, and the remaining patients improved after conservative treatment. "
02/28/2018 - "Among 12 cases who received conservative treatment without sufficient anticoagulation,the abdominal pain was relieved in only 2 cases (16.7%) and the remaining 10 cases (83.3%) were converted to surgical intervention. "
10/01/2014 - "Her abdominal pain and small bowel obstruction were improved with conservative treatment. "
04/01/2004 - "We present here a single case report of a patient with IBS who responded positively to SCS after failing all conservative therapies to alleviate or manage her abdominal pain and diarrheal episodes. "

01/01/1989 - "The authors believe that elective cholecystectomy is to be recommended (emergency cholecystectomy is associated with a high morbidity) as the children operated were improved by surgery, with resolution of abdominal pain."
01/01/1998 - "Although more than one-third complained of abdominal pain after cholecystectomy, 93% had improved or were cured. "
10/01/2015 - "The aim of this study was to determine characteristics associated with patient-reported absence of abdominal pain after cholecystectomy, improved abdominal symptoms, and patient-reported positive cholecystectomy results in a prospective cohort multicentre study. "
10/01/2011 - "Factors that predict relief from upper abdominal pain after cholecystectomy."
11/01/2006 - "Of the patients whose symptoms improved, those who underwent cholecystectomy had a quicker resolution of abdominal pain than those who did not undergo surgery. "

01/01/2021 - "However, one trial found that drug therapies that reduce gastric acidity improved gastro-intestinal symptoms such as abdominal pain; seven trials reported significant improvement in measures of fat malabsorption; and two trials reported no significant improvement in nutritional status. "
08/22/2016 - ", one trial found that drug therapies that reduce gastric acidity improved gastro-intestinal symptoms such as abdominal pain; seven trials reported significant improvement in measures of fat malabsorption; and two trials reported no significant improvement in nutritional status. "
07/13/2014 - ", one trial found that drug therapies that reduce gastric acidity improved gastro-intestinal symptoms such as abdominal pain; seven trials reported significant improvement in measures of fat malabsorption; and two trials reported no significant improvement in nutritional status. "
04/18/2012 - "However, one trial found that drug therapies that reduce gastric acidity improved gastro-intestinal symptoms such as abdominal pain; seven trials reported significant improvement in measures of fat malabsorption; and two trials reported no significant improvement in nutritional status. "
05/01/2008 - "The abdominal pain and appetite loss improved after the first course of chemotherapy, and therapeutic efficacy was rated PR. "